As the pharmaceutical industry increasingly embraces AI in drug discovery, a pressing question emerges: can AI go beyond merely delivering faster and cheaper drugs? Join our expert panel of C-level executives as they delve into the transformative potential of AI, exploring its capacity to foster true innovation rather than just incremental improvements. This session will unpack the critical distinction between imitation and genuine innovation, emphasizing why the latter is vital for developing groundbreaking therapies. Attendees will gain insights into the current capabilities and limitations of AI, as well as how it can empower scientists to uncover novel solutions that address unmet medical needs. Don’t miss this opportunity to engage in a forward-thinking discussion that could reshape the future of drug discovery.